Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC)
Clinical trial NCT05915351 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05915351
- Sponsor
- University of Kansas Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-30
- Primary completion
- 2025-06-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.